## **Lecture 1: DNA Structure and Organisation**

### ðŸ§¬ Key Concepts

- DNA consists of two **antiparallel strands** forming a **double helix**.
    
- **Base pairing:** Aâ€“T (2 H-bonds), Gâ€“C (3 H-bonds) â†’ Gâ€“C gives higher melting temperature.
    
- DNA has **polarity**: one strand runs 5â€²â†’3â€², the other 3â€²â†’5â€².
    

**Nucleic acids:**

- DNA = deoxyribose sugar (â€“H at 2â€²); RNA = ribose (â€“OH at 2â€²).
    
- **Purines:** adenine, guanine.
    
- **Pyrimidines:** cytosine, thymine (uracil in RNA).
    

**Chromosome organisation:**

- DNA wraps around **histone octamers** (H2A, H2B, H3, H4) forming a **nucleosome** (147 bp DNA).
    
- **H1** histone promotes 30 nm fibre condensation.
    
- **Chromatin:**
    
    - _Euchromatin_ â€“ active, loosely packed.
        
    - _Heterochromatin_ â€“ condensed, transcriptionally silent.
        
- Chromosomes = DNA + proteins; visible during mitosis.
    

**Clinical Focus:**  
G-banding and karyotyping identify chromosomal abnormalities (e.g., Down syndrome).

**DNA packaging hierarchy:**  
DNA â†’ nucleosome â†’ 30 nm fibre â†’ looped domain â†’ chromosome scaffold.  
Histone tails undergo **post-translational modifications** (acetylation = activation, methylation = variable).

**Exam Focus:**

- Draw and label a **nucleosome**.
    
- Define **histone H1** function.
    
- Explain **major vs minor groove**.
    

---

## **Repetitive DNA and Genome Organisation**

- Human genome â‰ˆ 3 billion bp; **genes < 5 %**.
    
- Non-coding DNA includes introns, regulatory regions, and repeats.
    

**Types of repetitive DNA:**

1. **Interspersed repeats:** LINEs and SINEs (retrotransposon-derived).
    
2. **Tandem repeats:** satellites (centromeres), minisatellites, microsatellites.
    

**Clinical Focus:**  
Microsatellite analysis â†’ forensic DNA fingerprinting.  
_Example:_ **Myotonic dystrophy** â€“ trinucleotide (CTG) repeat expansion in the _DMPK_ gene.

**Mitochondrial DNA (mtDNA):**

- Circular (~17 kb), **maternally inherited**.
    
- Used in **forensics**, **population ancestry (â€œOut of Africaâ€)**, and **disease genetics**.
    

---

## **Lecture 2: DNA Replication, Repair, and PCR**

### **Semi-Conservative Replication**

- **Meselson & Stahl (1958):** proved each daughter DNA = 1 parental + 1 new strand.
    
- **DNA polymerase:** synthesizes 5â€²â†’3â€², needs **RNA primer**.
    
- **Leading strand:** continuous; **Lagging strand:** Okazaki fragments joined by **ligase**.
    

**Key enzymes:**  
Helicase (unwinds) | Primase (lays primer) | DNA polymerase (elongation + proofreading) | Ligase (joins) | Topoisomerase (relieves tension).

### **End-Replication Problem**

- Lagging strand cannot fully replicate ends â†’ **telomere shortening**.
    
- **Telomerase** extends ends using internal RNA template.
    
- Active in **germ/stem cells** and **cancer**; silent in most somatic cells.
    

**Clinical Focus:**  
**Werner syndrome** â€“ helicase defect â†’ premature aging.

### **Mutation and Repair**

- DNA polymerase error = ~1/10â´ bp â†’ after proofreading â‰ˆ 1 error per 3 genomes.
    
- **Mismatch repair** fixes post-replication errors.
    

**Clinical Focus:**  
**Lynch syndrome (HNPCC)** â€“ mismatch repair defect â†’ colorectal cancer.

**Exam Focus:**

- Draw and label a **replication fork**.
    
- Know enzyme roles and directionality.
    

### **Polymerase Chain Reaction (PCR)**

1. **Denaturation 95 Â°C** â€“ strands separate.
    
2. **Annealing 50â€“65 Â°C** â€“ primers bind.
    
3. **Extension 72 Â°C** â€“ Taq polymerase extends strands.  
    (Repeat â‰ˆ 30 cycles â†’ exponential amplification.)
    

**Clinical Applications:**

- Detect pathogens (HIV, COVID-19).
    
- Genetic testing & carrier screening.
    
- Forensic identification.
    
- Copy-number variation analysis in cancer.
    

### **DNA Sequencing â€“ Sanger Method**

- Uses **dideoxynucleotides (ddNTPs)** to terminate chains.
    
- Fragments separated by **capillary electrophoresis** â†’ coloured peaks = sequence.
    

**Clinical Focus:**  
Detects **pathogenic mutations** (e.g., GFAP mutation â†’ Alexander disease).

**Exam Focus:**

- Memorize **PCR steps + temperatures**.
    
- Understand **how ddNTPs terminate** in Sanger sequencing.
    

---

## **Lecture 3: Transcription, RNA Processing, and Regulation**

### **DNA vs RNA**

|Feature|DNA|RNA|
|---|---|---|
|Sugar|Deoxyribose (no â€“OH 2â€²)|Ribose (â€“OH 2â€²)|
|Bases|A, T, G, C|A, U, G, C|
|Structure|Double helix|Single-stranded, folds into structures|
|Function|Information storage|Diverse roles: messenger, catalytic, regulatory|

**Exam Focus:** RNA is chemically less stable â†’ shorter lifespan.

---

### **Transcription Overview**

- DNA template strand â†’ complementary RNA (5â€²â†’3â€²).
    
- No primer required; less accurate than DNA replication.
    
- Multiple RNA copies can form simultaneously.
    

**RNA Polymerases (Eukaryotes):**

- **Pol I:** rRNA (except 5S)
    
- **Pol II:** mRNA, snRNA, miRNA
    
- **Pol III:** tRNA, 5S rRNA
    

**Clinical Focus:**  
Î±-Amanitin (from mushrooms) inhibits RNA Pol II â†’ â†“ mRNA â†’ liver failure.

---

### **Promoters and Enhancers**

**Promoter:**

- Region upstream of transcription start site.
    
- **TATA box** (~25 bp upstream) binds TBP â†’ DNA bending.
    
- **CAAT** and **GC boxes** bind transcription factors (TFIIB, TFIID etc.).
    
- Housekeeping genes often lack TATA box but have GC boxes.
    

**Enhancer:**

- Short sequence that increases transcription efficiency.
    
- Works at distance; orientation-independent.
    
- Binds specific transcription factors â†’ DNA looping.
    
- Opposed by **silencers** (repressors).
    

**Exam Focus:**

- Distinguish **promoter vs enhancer**.
    
- Know **TATA box position and function**.
    

---

### **Transcription Factors**

- Contain two domains: DNA-binding and activation.
    
- Respond to signals (e.g., hormones, growth factors).
    

**Signal Response:**  
External signals â†’ activate transcription factors â†’ gene transcription changes.

---

### **RNA Processing (Post-Transcriptional Modifications)**

1. **5â€² Cap (7-methyl-G):** protects from degradation + helps ribosome binding.
    
2. **Splicing:**
    
    - Introns removed, exons joined by **spliceosome (snRNPs)**.
        
    - Occurs via two trans-esterification reactions forming a **lariat**.
        
    - Splice sites = GU (5â€²) and AG (3â€²).
        
3. **3â€² Poly-A Tail:** increases mRNA stability and export.
    

**Clinical Focus:**  
Splicing errors â†’ genetic disease (e.g., Î²-thalassemia from abnormal splice site).

**Exam Focus:**

- Sketch pre-mRNA â†’ mature mRNA (capping, splicing, tail).
    
- Remember GUâ€“AG rule and lariat formation.
    

---

### **Alternative Splicing**

- Allows 1 gene â†’ many mRNAs â†’ multiple proteins (isoforms).
    
- Exon order preserved but inclusion/exclusion varies.
    

**Clinical Focus:**  
**Frasier syndrome** â€“ WT1 gene mis-splicing â†’ renal failure / gonadal abnormalities.

**Gene Number Paradox:**  
Humans (~20 k genes) produce >100 k proteins.  
â†’ Explained by alternative splicing, alternative promoters/3â€² ends, RNA editing, and post-translational modifications.

**Exam Focus:**

- Explain the gene number paradox.
    
- Give examples of how one gene â†’ multiple proteins.
    

---

# âœ… **Overall Summary of Key Exam & Clinical Points**

| Area                     | Exam Focus                                 | Clinical Focus                         |
| ------------------------ | ------------------------------------------ | -------------------------------------- |
| **DNA structure**        | Antiparallel helix, base pairing, grooves  | Karyotyping abnormalities              |
| **Chromatin**            | Histone roles + modifications              | Epigenetic changes in cancer           |
| **Replication**          | Enzymes, fork direction, Okazaki fragments | Werner syndrome                        |
| **Repair**               | Proofreading vs MMR timing                 | Lynch syndrome                         |
| **PCR/Sequencing**       | Steps + temperatures / ddNTP mechanism     | Genetic testing and mutation detection |
| **Transcription**        | RNA Pol Iâ€“III + promoter/enhancer roles    | Î±-Amanitin toxicity                    |
| **RNA processing**       | Cap, splicing, poly-A tail sequence        | Î²-thalassemia, Frasier syndrome        |
| **Alternative splicing** | Gene number paradox                        | Protein isoform diversity in disease   |